Ads
related to: mbrx stock pricelp.stockstotrade.com has been visited by 10K+ users in the past month
Search results
Moleculin (MBRX) Posts Update From Lung Cancer Study, Stock Up
Zacks via Yahoo Finance· 8 months agoMoleculin (MBRX) completes enrollment in the phase II portion of the development program for its...
Moleculin Biotech, Inc. (MBRX) Upgraded to Buy: What Does It Mean for the Stock?
Zacks via Yahoo Finance· 1 year agoMoleculin Biotech, Inc. (MBRX) might move higher on growing optimism about its earnings prospects,...
Here's Why We're A Bit Worried About Moleculin Biotech's (NASDAQ:MBRX) Cash Burn Situation
Simply Wall St. via Yahoo Finance· 5 months agoEven when a business is losing money, it's possible for shareholders to make money if they buy a...
Lantheus (LNTH) to Report Q4 Earnings: What's in the Cards?
Zacks via Yahoo Finance· 3 months agoLantheus Holdings, Inc. LNTH is scheduled to release fourth-quarter 2023 results on Feb 22, before...
What's Going On With Moleculin Biotech Stock Today?
Benzinga via Yahoo Finance· 1 year agoMoleculin Biotech Inc (NASDAQ: MBRX) announced that preclinical data regarding its next-generation anthracycline, Annamycin, was presented at the...
Moleculin Biotech's Annamycin In Leukemia Study Shows 80% Overall Response Rate
Benzinga via Yahoo Finance· 1 year agoMoleculin Biotech Inc (NASDAQ: MBRX) provided an update on its clinical programs evaluating...
Moleculin Biotech's Potential Antiviral Compound Selected For NIAID-Funded Animal Studies
Benzinga via Yahoo Finance· 2 years agoMoleculin Biotech Inc (NASDAQ: MBRX) announced that its WP1096 molecule would be evaluated in animal...
Moleculin Reveals Final Topline Data From European Study Of Annamycin In Leukemia Setting
Benzinga via Yahoo Finance· 1 year agoMoleculin Biotech Inc (NASDAQ: MBRX) announced the topline results from its MB-105 European Phase 1...